- Investing Ideas
- Global Pharmaceuticals & Biotech High Return On Equity, Low Debt
Global Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
48
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
48 companies
Roche Holding
Market Cap: CHF 291.6b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 364.80
7D
0.9%
1Y
34.6%
Exelixis
Market Cap: US$14.5b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$57.22
7D
1.8%
1Y
44.6%
Orion Oyj
Market Cap: €11.7b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€82.85
7D
4.0%
1Y
23.0%
ALTEOGEN
Market Cap: ₩17.8t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩249,500.00
7D
-4.0%
1Y
-32.7%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥45.9b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥103.18
7D
4.4%
1Y
-2.1%
Abbott India
Market Cap: ₹573.0b
Operates as a pharmaceutical company in India.
500488
₹27,223.20
7D
4.1%
1Y
-10.0%
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥37.8b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥41.56
7D
3.8%
1Y
13.1%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹485.2b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,871.50
7D
2.0%
1Y
4.0%
Suzhou Zelgen Biopharmaceuticals
Market Cap: CN¥31.6b
Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.
688266
CN¥118.55
7D
7.4%
1Y
12.8%
SK Biopharmaceuticals
Market Cap: ₩6.1t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩76,800.00
7D
-1.7%
1Y
-30.4%
Xiamen Amoytop Biotech
Market Cap: CN¥20.5b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥52.16
7D
4.3%
1Y
-33.8%
ADMA Biologics
Market Cap: US$2.1b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$9.51
7D
10.4%
1Y
-40.5%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥13.3b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥37.16
7D
2.9%
1Y
-18.6%
Genus
Market Cap: UK£1.4b
Produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia.
GNS
UK£21.20
7D
-0.7%
1Y
-13.1%
MeiraGTx Holdings
Market Cap: US$1.3b
A clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases.
MGTX
US$13.08
7D
1.6%
1Y
61.7%
BioGaia
Market Cap: SEK 11.1b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 109.60
7D
2.1%
1Y
-0.6%
Basilea Pharmaceutica
Market Cap: CHF 856.9m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 69.00
7D
4.4%
1Y
47.0%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩36,200.00
7D
4.6%
1Y
-24.3%
Sanofi India
Market Cap: ₹70.9b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,056.10
7D
-2.4%
1Y
-38.9%
CorMedix
Market Cap: US$601.7m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.77
7D
-1.5%
1Y
-31.1%
Jacobio Pharmaceuticals Group
Market Cap: HK$4.7b
An investment holding company, engages in the in-house discovery and development of oncology therapies in the People’s Republic of China.
1167
HK$5.95
7D
3.8%
1Y
-39.5%
Rafa Laboratories
Market Cap: ₪1.6b
A pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel.
RAFA
₪16.29
7D
2.2%
1Y
n/a
GlaxoSmithKline Pakistan
Market Cap: PK₨102.7b
A biopharma company, engages in the discovery, development, and delivery of medicines and vaccines in Pakistan.
GLAXO
PK₨322.61
7D
7.5%
1Y
-28.2%
Q32 Bio
Market Cap: US$313.8m
A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.
QTTB
US$10.47
7D
-4.0%
1Y
459.9%
Shukra Pharmaceuticals
Market Cap: ₹24.3b
Engages in the manufacturing, marketing, and export of pharmaceutical formulations in India and internationally.
524632
₹58.73
7D
6.2%
1Y
80.7%
Compugen
Market Cap: US$235.9m
A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.
CGEN
US$2.44
7D
-1.8%
1Y
70.3%
BLS Pharmaceuticals
Market Cap: AU$277.5m
Manufactures, imports, exports, and supplies controlled drugs and prescription medicines in Australia, the United Kingdom, Europe, and Japan.
BLS
AU$1.18
7D
0.4%
1Y
210.5%
Hester Biosciences
Market Cap: ₹18.6b
Manufactures and trades in veterinary vaccines and health products in India and internationally.
524669
₹2,182.10
7D
0.7%
1Y
10.6%
Highnoon Laboratories
Market Cap: PK₨49.7b
Together with its subsidiary, engages in the development, production, marketing, and distribution of pharmaceutical and allied consumer products in Pakistan, Afghanistan, the United Arab Emirates, Sri Lanka, France, Sudan, Cambodia, Kenya, Iraq, Dubai, Tanzania, and internationally.
HINOON
PK₨938.51
7D
1.8%
1Y
-16.9%
Alexandria For Pharmaceuticals & Chemical Industries
Market Cap: ج.م8.4b
Operates as a pharmaceutical company in Egypt.
AXPH
ج.م1,650.37
7D
-0.9%
1Y
138.7%
Kahira Pharmaceuticals & Chemical Industries
Market Cap: ج.م8.3b
Manufactures, packages, distributes, and trades in pharmaceutical products in Egypt and internationally.
CPCI
ج.م558.97
7D
5.4%
1Y
149.6%
Quality Chemical Industries
Market Cap: USh588.0b
Engages in the manufactures and sells pharmaceutical drugs in Uganda.
QCIL
USh161.00
7D
0.6%
1Y
36.4%
Hoechst Pakistan
Market Cap: PK₨38.0b
Together with its subsidiary, manufactures, sells, and trades in pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨3,937.39
7D
-0.6%
1Y
-1.7%
Saniona
Market Cap: SEK 1.3b
A clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 9.55
7D
-5.7%
1Y
-22.2%
JW Shinyak
Market Cap: ₩181.0b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩3,200.00
7D
-13.0%
1Y
124.6%
NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag
Market Cap: Ft39.0b
Manufactures and sells pharmaceutical products in Hungary.
NATURLAND
Ft2,820.00
7D
0%
1Y
8.5%